Inkef
Amsterdam-based early-stage venture capital firm backing technology and life sciences companies, primarily at Series A, with a long-term, hands-on approach.
Inkef is an early-stage venture capital firm headquartered in Amsterdam. Its primary investment focus is Series A funding for technology and life sciences companies, with seed funding considered for exceptional founding teams and growth capital reserved for existing portfolio companies preparing their next step. The firm works with entrepreneurs from the earliest stages of company building, with the stated ambition of turning ideas into international businesses.
Sector coverage spans software, enterprise SaaS, deep tech, digital health and therapeutics, alongside life sciences more broadly. Portfolio companies are supported with an international reach in mind, notwithstanding the firm's single European base. Fund size, team size and founding year are not disclosed in the materials reviewed.
Inkef describes its approach as hands-on and long-horizon, working alongside founders over time rather than across a short holding period. Its stated guiding principle is the creation of lasting value and sustainable returns through the construction of durable businesses - a framing that emphasises company building over transaction volume. Check sizes and formal decision-making processes are not published.